Family Communication Following BRCA1/2 Genetic Testing: A Close Look at the Process

被引:29
|
作者
Lafreniere, Darquise [1 ]
Bouchard, Karine [2 ,3 ]
Godard, Beatrice [1 ]
Simard, Jacques [4 ,5 ]
Dorval, Michel [2 ,3 ,6 ]
机构
[1] Univ Montreal, Fac Med, Dept Med Sociale & Prevent, Programmes Bioeth, Montreal, PQ H3C 3J7, Canada
[2] Hop St Sacrement, Ctr Rech CHU Quebec, Unite Rech Sante Populat, Quebec City, PQ, Canada
[3] Hop St Sacrement, CHU Quebec, Ctr Malad Sein Deschenes Fabia, Quebec City, PQ, Canada
[4] Univ Laval, Fac Med, Dept Med Mol, Quebec City, PQ G1K 7P4, Canada
[5] CHUL, Ctr Rech CHU Quebec, Lab Genom Canc, Quebec City, PQ, Canada
[6] Univ Laval, Fac Pharm, Quebec City, PQ, Canada
基金
加拿大健康研究院;
关键词
Genes; BRCA1; BRCA2; Communication; Family; Genetic predisposition to disease; Psychosocial factors; CANCER-RISK ASSESSMENT; OVARIAN-CANCER; HEREDITARY BREAST; DECISION-MAKING; INFORMATION; RELATIVES; MUTATION; WOMEN; METHODOLOGY; NONCARRIERS;
D O I
10.1007/s10897-012-9559-x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
This study examines the process of communicating BRCA1/2 genetic test results to family members, and the factors influencing disclosure. Twenty-nine semi-structured telephone interviews with BRCA1/2 tested individuals, 4 to 9 years post-notification, were conducted. Our results suggest that individual, familial, relational and socio-medical factors influence the decision to disclose/not disclose genetic test results to family members. These factors are at play in all three communication phases: the Decision-making phase, in which the individual ponders various factors before deciding to disclose test results to family members; the Disclosure phase, in which communication per se takes place; and the Reaction phase, which shapes the participant's subsequent disclosure/non-disclosure decisions. We propose a guiding framework to assist in identifying and evaluating significant factors that might shape the course and outcome of the transmission of genetic information to family members.
引用
收藏
页码:323 / 335
页数:13
相关论文
共 50 条
  • [41] Timing of BRCA1/BRCA2 genetic testing in women with ovarian cancer
    Daniels, Molly S.
    Urbauer, Diana L.
    Stanley, Jennifer L.
    Johnson, Kristin G.
    Lu, Karen H.
    GENETICS IN MEDICINE, 2009, 11 (09) : 624 - 628
  • [42] Impact of predictive genetic testing for BRCA1 and BRCA2 in young people
    Beach, Anna
    Knopp, J.
    Kerzin-Storrat, L.
    Evans, G.
    MacLeod, R.
    JOURNAL OF MEDICAL GENETICS, 2012, 49 : S21 - S21
  • [43] Cost-effectiveness of genetic testing for BRCA1 and BRCA2 mutations
    Ozanne, E. M.
    Cipriano, L.
    Cameron, M.
    Newman, T.
    Esserman, L. J.
    CANCER RESEARCH, 2009, 69 (02) : 377S - 377S
  • [44] Family history of pancreatic cancer in BRCA1/2 testing criteria
    Toss, A.
    Venturelli, M.
    Pipitone, S.
    Marchi, I.
    Tenedini, E.
    Medici, V.
    Tagliafico, E.
    Razzaboni, E.
    Spaggiari, F.
    De Matteis, E.
    Cascinu, S.
    Cortesi, L.
    ANNALS OF ONCOLOGY, 2017, 28 : 48 - 48
  • [45] Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk families
    Katapodi, Maria C.
    Northouse, Laurel L.
    Milliron, Kara J.
    Liu, Guipeng
    Merajver, Sofia D.
    PSYCHO-ONCOLOGY, 2013, 22 (06) : 1336 - 1343
  • [46] Quality of life for women seeking BRCA1/2 genetic testing: Impact of family cancer history
    Lesniak, KT
    Keenan, LA
    Guarnaccia, CA
    Althaus, BW
    Ethington, GM
    Blum, JL
    PSYCHOSOMATIC MEDICINE, 2001, 63 (01): : 126 - 127
  • [47] Parental communication of BRCA1/2 genetic test results to children
    Tercyak, KP
    Hughes, C
    Main, D
    Snyder, C
    Lynch, JF
    Lynch, HT
    Lerman, C
    PATIENT EDUCATION AND COUNSELING, 2001, 42 (03) : 213 - 224
  • [49] A review of BRCA1 & BRCA2 testing
    Lillis, S
    Mattocks, C
    Tarpey, P
    Daboo, L
    Whittaker, J
    JOURNAL OF MEDICAL GENETICS, 2003, 40 : S72 - S72
  • [50] Determinants in the uptake of genetic testing for BRCA1/2 mutations.
    Fowler, ES
    neese, ER
    Schwartzberg, LS
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S166 - S166